News About: Pharm. Industry
Overseas pharmaceutical sales information by nation and therapeutic category.
1. Sales by nation.
Nation 98 sales(U$1Bil.) Market share (%) G/R(%)
USA 99.5 39.6 +11
Japan 38.8 15.4 -1
German...
Hanil Pharm. Co. faces on critical edge of bankruptcy
The management control of Hanil Pharmaceutical company was transferred to Shin Dong-A group as a subsidiary in the general shareholder's meeting last year, but as of Apr. 2 this year the company was unable to pay the ...
Japanese bsuiness operation in Korean drug industry on ever expanding.
Japanese pharmaceutical corporations have engaged in their partial joint venture or licensing business with local business counterpartners, but from the latter part of 1990s they expanded their business management con...
KRPIA proposed imported drug insurance pricing based on G7 ex-factory prices.
The KRPIA asked to the government for the imported drug pricing to be determined on the basis of ex-factory prices exercised at the G7 advanced countries as scheduled to take effect from July 1, this year.
On March...
Overall KFDA reforms including clinical study system planned to complete earlier.
Mr. Choi Soo-young, the director of Drug Safety Bureau of KFDA, addressed a lecture at the 45th anniversary meeting of Yakup Shinmoon foundation under the title of "the pharmaceutical issues and policies in 21st centu...
KPMA opens membership to foreign drug companies.
The KPMA decided in the executive meeting on March 24 that the eligibility for KPMA membership widely opened to the foreign multinational drug companies regardless of the manufacturing facility located in Korea if the...
Pharmaceutical company increased cash account and reduced debt ratio.
According to "Financial analysis and investment advice of pharmaceutical industry" reported by Mr. Ha Tae-ki, the assistant manage in charge of pharmaceutical business, SK security company after analysing the financia...
M&A and Big Deals in pharmaceutical industry rootlessly rumoured
Rootless rumours widely spreaded that big deals between the top drug makers and M&A by domestic conglomerates were attempted, which was voiced loudly in the stock exchange market where "the confidential letter for int...
5 listed drug makers announced to give dividends.
The Korea Stock Exchange announced publicly that 5 drugs makers including Bukwang (fiscal year closed at Dec. 31, 1998) planned to pay dividends to their stockholders.
Bukwang will pay 0.1 stock per a stock or in c...
Advertising and marketing promotion activity extremely slow due to IMF economic difficulties.
According to the financial analysis against KSE listed drug companies (account closing at Dec. 31), he advertising and market promotional expenditures in 1998 recorded extremely low by 33% and 20% decreases over the p...
